[1]
S. Lepori, C. Fontanella, G. Maltese, and D. Lorusso, “Evaluation of capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma: a retrospective study of the IRCCS National Cancer Institute of Milan:  ”, CBN, vol. 4, no. 3, pp. 25–29, Dec. 2016.